Duodenal Jejunal Bypass Liner (DJBL) for treatment of type 2 diabetes and obesity: the risk benefit ratio from the worldwide EndoBarrier (EB) registry in 871 patients

被引:0
|
作者
Laubner, K. [1 ]
Seufert, J. [1 ]
Aberle, J. [2 ]
Frydenberg, H. [3 ]
Munro, L. [3 ]
Fishman, S. [4 ]
Cohen, R. [5 ]
Holtmann, G. [6 ]
de Jonge, C. [7 ]
Greve, J. [7 ]
Kow, L. [8 ]
Bessell, J. [9 ]
Sourij, H. [10 ]
Benes, M.
Ryder, R. E. J. [11 ]
机构
[1] Freiburg Univ, Freiburg, Germany
[2] Hamburg Univ, Hamburg, Germany
[3] Epworth Med Fdn, Richmond, Australia
[4] Sourasky Med, Tel Aviv, Israel
[5] Oswaldo Cruz Hosp, Sao Paulo, Brazil
[6] Princess Alexandra Hosp, Woolloongabba, Qld, Australia
[7] MUMC, Maastricht, Netherlands
[8] ABC, Adelaide, SA, Australia
[9] AOS, Adelaide, SA, Australia
[10] Med Univ, Graz, Austria
[11] City Hosp, Birmingham, W Midlands, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
803
引用
收藏
页码:S390 / S390
页数:1
相关论文
共 50 条
  • [31] Duodenal-Jejunal Bypass Liner to Treat Type 2 Diabetes Mellitusin Morbidly Obese Patients
    Munoz, Rodrigo
    Escalona, Alex
    CURRENT CARDIOLOGY REPORTS, 2014, 16 (03)
  • [32] Duodenal-Jejunal Bypass Liner to Treat Type 2 Diabetes Mellitus in Morbidly Obese Patients
    Rodrigo Muñoz
    Alex Escalona
    Current Cardiology Reports, 2014, 16
  • [33] The Effect of 6 and 12 months Duodenal-Jejunal Bypass Liner Treatment on Obesity and Type 2 Diabetes: a Crossover Cohort Study
    van Rijn, Selwyn
    Betzel, Bark
    de Jonge, Charlotte
    van Dijk, David P. J.
    Janssen, Ignace M.
    Berends, Frits J.
    Bouvy, Nicole D.
    Greve, Jan Willem M.
    OBESITY SURGERY, 2018, 28 (05) : 1255 - 1262
  • [34] Endoscopic Duodenal-Jejunal Bypass Liner (Endobarrier) Improves Hepatic Parameters of Nonalcoholic Fatty Liver Disease in Obese Uncontrolled type 2 Diabetes Mellitus Patients
    Cohen-Ezra, Oranit
    Segal-Lieberman, Gabriella
    Lang, Alon
    Lahav, Maor
    Kleinbaum, Yeroham
    Katsherginsky, Sima
    Tsaraf, Keren
    Ben Ari, Ziv
    HEPATOLOGY, 2014, 60 : 607A - 607A
  • [35] Duodenal-Jejunal Bypass Liner for the management of Type 2 Diabetes Mellitus and Obesity: A Multicenter Randomized Controlled Trial
    Ruban, Aruchuna
    Miras, Alexander D.
    Glaysher, Michael A.
    Goldstone, Anthony P.
    Prechtl, Christina G.
    Johnson, Nicholas
    Chhina, Navpreet
    Al-Najim, Werd
    Aldhwayan, Madhawi
    Klimowska-Nassar, Natalia
    Smith, Claire
    Lord, Joanne
    Li, Jia V.
    Flores, Lilliam
    Al-Lababidi, Moaz
    Dimitriadis, Georgios K.
    Patel, Mayank
    Moore, Michael
    Chahal, Harvinder
    Ahmed, Ahmed R.
    Cousins, Jonathan
    Aldubaikhi, Ghadah
    Glover, Ben
    Falaschetti, Emanuela
    Ashrafian, Hutan
    Le Roux, Carel W.
    Darzi, Ara
    Byrne, James P.
    Teare, Julian P.
    ANNALS OF SURGERY, 2022, 275 (03) : 440 - 447
  • [36] Endobarrier™ Duodenal-Jejunal Bypass Treatment Results in Excess Weight Loss and Rapid Improvement of Diabetes in Obese Type 2 Diabetic Patients
    Bouvy, N. D.
    de Jonge, C.
    Greve, J.
    OBESITY SURGERY, 2011, 21 (08) : 970 - 970
  • [37] Pilot Clinical Study of an Endoscopic, Removable Duodenal-Jejunal Bypass Liner for the Treatment of Type 2 Diabetes
    Rodriguez, Leonardo
    Reyes, Eliana
    Fagalde, Pilar
    Oltra, Maria Soledad
    Saba, Jorge
    Aylwin, Carmen Gloria
    Prieto, Carolina
    Ramos, Almino
    Galvao, Manoel
    Gersin, Keith S.
    Sorli, Christopher
    DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 (11) : 725 - 732
  • [38] The Effect of the Endoscopic Duodenal-Jejunal Bypass Liner on Obesity and Type 2 Diabetes Mellitus, a Multicenter Randomized Controlled Trial
    Koehestanie, Parviez
    de Jonge, Charlotte
    Berends, Frits J.
    Janssen, Ignace M.
    Bouvy, Nicole D.
    Greve, Jan Willem M.
    ANNALS OF SURGERY, 2014, 260 (06) : 984 - 992
  • [39] Efficacy and safety of duodenal-jejunal bypass liner for obesity and type 2 diabetes: A systematic review and meta-analysis
    Chen, Wenhui
    Feng, Jia
    Dong, Shiliang
    Guo, Jie
    Zhou, Fuqing
    Hu, Songhao
    Hu, Ruixiang
    Wang, Cunchuan
    Ma, Yi
    Dong, Zhiyong
    OBESITY REVIEWS, 2024, 25 (11)
  • [40] A MULTICENTER RANDOMIZED SHAM-CONTROLLED TRIAL OF A DUODENAL JEJUNAL BYPASS LINER FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS
    Thompson, Christopher C.
    Jirapinyo, Pichamol
    Brethauer, Stacy
    Shaheen, Nicholas J.
    Sullivan, Shelby A.
    Koch, Timothy R.
    Reavis, Kevin M.
    Abu Dayyeh, Barham K.
    Wilson, Erik B.
    Schulman, Allison R.
    Butsch, W. Scott
    Apovian, Caroline M.
    Schauer, Philip
    GASTROINTESTINAL ENDOSCOPY, 2022, 95 (06) : AB10 - AB11